Clinical Trial Update: Treosulfan-based Conditioning for Transplantation in AML/MDS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treosulfan-based conditioning for transplantation in acute myeloid leukemia and myelodysplastic syndrome. The study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: Dr. Avichai Shimoni MD | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED